CCL25 levels in EM PF and the expression of CCR9 on M-MDSCs were measured by ELISA. M-MDSC migration was determined towards rhCCL25, 伪-CCR9, 伪-CCL25 and EM PF through in-vitro chemotaxis assay. CD33+ CD14+ CD11b+ HLA-DR- M-MDSCs isolated from EM PBMCs were added to CD8+ ...
1急性淋巴细胞白血病的免疫表型多显示A.CD33、CD13、CD14、CD15及HLA-DR阳性B.CD3、CD7、CD2及HLA-DR阳性C.CD41a、CD41b及HLA-DR阳性D.CD41a、CD41b及PPO阳性E.CD10、CD13、CD15及PPO阳性 2急性淋巴细胞白血病的免疫表型多显示 A.CD33、CD13、CD14、CD15及HLA-DR阳性B.CD3、CD7、CD2及HLA-DR阳性C.CD...
In conclusion, there is a link among CD14(+)CD33(+) myeloid cells, CCL11, and eosinophils in adult UC. 展开 关键词: inflammatory bowel disease eotaxins chemokine DOI: 10.1189/jlb.1212640 被引量: 35 年份: 2013 收藏 引用 批量引用 报错 分享 ...
淋巴瘤患者外周血中髓样抑制细胞的鉴定及临床意义 目的:探讨淋巴瘤患者外周血中髓样抑制细胞(myeloid-derived suppressor cells,MDSCs)的表达情况及临床意义. 方法:采用流式细胞技术,通过抗CD11b,CD33,CD14,HLA-DR... BAO Huizheng,鲍慧铮,TIAN Tian,... - 中国老年学学会 被引量: 0发表: 2015年 加载更多来源...
百度试题 题目原始粒细胞常表达下列哪些抗原 A. CD117、CD38、HLA-DR B. CD34、CD15、CD11b C. MPO、CD33、CD14 D. CD117、CD15、CD11b E. CD34、CD11b、CD10 相关知识点: 试题来源: 解析 A.CD117、CD38、HLA-DR 反馈 收藏
急性淋巴细胞白血病的免疫表型多显示 A. CD33、CD13、CD14、CD15及HLA-DR 阳性 B. CD3、CD7、CD2及HLA-DR阳性 C. CD41a、CD41b及HLA-DR阳性 D. CD41a、CD41b及PPO阳性 E. CD10、CD13、CD15及PPO阳性 相关知识点: 试题来源: 解析 B 反馈 收藏 ...
(HLA-DR−/lowCD11b+CD33+CD14−CD15+), CD11b+CD14−CD15+cells (alternative definition of G-MSCSs), HLA-DR−/lowCD14+cells (alternative definition of M-MSCSs), and HLA-DR−/lowCD33+CD16−cells in the peripheral blood from ten healthy donors before (homeostasis peripheral blood...
急性T淋巴细胞白血病可出现的免疫表型是 A. CD10、CD19 B. CD33、CD34 C. CD5、CD7 D. CD20、HLA-DR E. CD14、CD64
急性巨核细胞白血病的细胞免疫表型是 A. CD33、CD13、CD14、CD15及HLA-DR阳性 B. CD19、CD20、CD22、SIg及HLA-DR阳性 C. CD41a、CD11b及HLA-DR阳性 D. CD41a、CD41b及PPO阳性 E. CD10、CD62、CD15及PPO阳性 相关知识点: 试题来源: 解析 D 反馈 收藏 ...
CD33+ populations within the TME are enriched for HLA-DR– populations and comprise different MDSC sub- sets, including C D33+HLA-DR–CD14+CD15– monocytic MDSCs, CD33+CD14+CD15– polymorphonuclear MDSCs and CD33+HLA-DR–CD14–CD15– immature or early-stage MDSCs [32]. Since...